Physician profile
David Moore
NPI 1598737413
$1,635.22
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,151 · 2020: $173 · 2021: $40.27 · 2023: $126 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $501.52 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $414.11 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $269.70 | 2019-2020 | |
| Genentech USA, INC. | $150.49 | 2019-2023 | Enspryng |
| E.R. Squibb & Sons, L.L.C. | $130.05 | 2024 | Zeposia |
| Genzyme Corporation | $52.40 | 2019 | |
| Ucb, INC. | $43.58 | 2019-2020 | |
| Lundbeck LLC | $23.98 | 2019 | |
| Emd Serono, INC. | $19.46 | 2019 | |
| Greenwich Biosciences, INC. | $18.48 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.